Cosmo Accelerates Global ESG Leadership with Major Ratings Upgrades, UN Compact Commitment, and Climate Action Pledge
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 16 2025
0mins
Should l Buy ?
Source: Yahoo Finance
Cosmo Pharmaceuticals' Sustainability Achievements: The company has made significant progress in its sustainability efforts, achieving an MSCI ESG Rating upgrade to "A" and doubling its LSEG ESG Score, now ranking #42 globally among peers.
Commitment to ESG Initiatives: Cosmo has joined the UN Global Compact and committed to the Science Based Targets initiative (SBTi), emphasizing that environmental, social, and governance factors are integral to its business strategy and future growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
